6:35 PM
 | 
Dec 15, 2011
 |  BC Extra  |  Company News

Shire, Atlas to invest in early rare disease ventures

Shire plc (LSE:SHP; NASDAQ:SHPGY) partnered with Atlas Ventures to create and fund newcos based on early stage assets to treat rare...

Read the full 89 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >